A survey of the frequency of cytomegalovirus-associated diarrhea in immunocompromised patients using a non-invasive method
Abstract
Background and Objectives: Cytomegalovirus (CMV) infection is the most common viral opportunistic infection causing gastrointestinal diseases such diarrhea and colitis in immunocompromised patients. The development and performance of a robust and sensitive PCR assay are usually evaluated to detect CMV DNA in human fecal specimens. In this study, our aim was to detect CMV DNA in stool samples taken from patients with HIV/AIDS, cancer, and transplant recipient patients with chronic and persistent diarrhea using a non-invasive method.
Materials and Methods: A total of 633 immunocompromised patients (451 males and 182 females) suffering from persistent or chronic diarrhea were included in this study. Among them, 392 were HIV/AIDS patients, 151 had cancer and were receiving chemotherapy, and 90 were recipients of a solid organ or bone marrow transplant. CMV genome was extracted from the stool samples using phenol: chloroform: isoamyl alcohol method. CMV DNA was identified by polymerase chain reaction using sequence specific primers on genomic DNA.
Results: Looking at the frequency of CMV DNA in 392 HIV/AIDS patients, we found that only 5 patients (1.27%) were positive for CMV genome, while this frequency was 4.63% (7/151) and 5.5% (5/90) in patients with cancer receiving chemotherapy and in those with solid organ or bone marrow transplant, respectively.
Conclusion: The results of this study revealed that the cause of chronic or persistent diarrhea in HIV/AIDS, cancer, and graft recipient patients might be related to CMV infection. Accordingly, we recommend a non-invasive method, such as stool sample, as a first line of diagnosis of enteritis when the physician suspects that a patient has CMV infection.
Agholi M, Heidarian HR, Moghadami M, Hatam GR. First detection of a calculous cholecystitis associated with Sarcocystis infection in a patient with AIDS. Acta Parasitol 2014;59:310-315.
Agholi M, Shahabadi SN, Motazedian MH, Hatam GR. Prevalence of enteric protozoan oocysts with special reference to Sarcocystis cruzi among fecal samples of diarrheic immunodeficient patients in Iran. Korean J Parasitol 2016;54:339-344.
Lautenschlager I. CMV infection, diagnosis and antiviral strategies after liver transplantation. Transpl Int 2009;22:1031-1040.
Marashi SM, Raeiszadeh M, Workman S, Rahbar A, Soderberg-Naucler C, Klenerman P, et al. Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus. J Allergy Clin Immunol 2011;127:1385-1393.e4.
Herbein G, Kumar A. The oncogenic potential of human cytomegalovirus and breast cancer. Front Oncol 2014;4:230.
Lin MW LJ, Chang KJ, Lee PH, Lin BR. Cytomegalovirus colitis in an immunocompetent patient: report of a case and review of the literature. J Soc Colon Rectal Surgeon 2008;19:27-31.
Rubin RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990;12 Suppl 7:S754-766.
Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993;119:924-935.
Chang HR, Lian JD, Chan CH, Wong LC. Cytomegalovirus ischemic colitis of a diabetic renal transplant recipient. Clin Transplant 2004;18:100-104.
Merrikhi AR, Amir-Shahkarami SM, Saneian H. Cytomegalovirus colitis in a 10 year-old girl after kidney transplantation. Iran J Pediatr 2013;23:220-222.
Maes B, Hadaya K, de Moor B, Cambier P, Peeters P, de Meester J, et al. Severe diarrhea in renal transplant patients: results of the DIDACT study. Am J Transplant 2006;6:1466-1472.
Serwadda D, Mugerwa RD, Sewankambo NK, Lwegaba A, Carswell JW, Kirya GB, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet 1985;2:849-852.
Safaie N, Ghotaslou R, Montazer Ghaem H. Seroprevalence of cytomegalovirus in patients with and without coronary artery diseases at Madani Heart Center, Iran. Acta Med Iran 2010;48:403-406.
Mehrkhani F, Jam S, Sabzvari D, Fattahi F, Kourorian Z, SeyedAlinaghi S, et al. Cytomegalovirus co-infection in patients with human immunodeficiency virus in Iran. Acta Med Iran 2011;49:551-555.
Marashi S, Tabatabaei H, Mahmoodi M, Nategh R, Mokhtari-Azad T. Prevalence of rubella and HCMV antibodies among neonates with congenital defects in four provinces of Iran. Iran J Virol 2011;5:34-39.
Tabatabaee M, Tayyebi D. Seroepidemiologic study of human cytomegalovirus in pregnant women in Valiasr Hospital of Kazeroon, Fars, Iran. J Matern Fetal Neonatal Med 2009; 22:517-521.
Drew WL. Cytomegalovirus infection in patients with AIDS. J Infect Dis 1988;158:449-456.
Reed EC, Shepp DH, Dandliker PS, Meyers JD. Ganciclovir treatment of cytomegalovirus infection of the gastrointestinal tract after marrow transplantation. Bone Marrow Transplant 1988;3:199-206.
Numazaki K, Chiba S. Current aspects of diagnosis and treatment of cytomegalovirus infections in infants. Clin Diagn Virol 1997;8:169-181.
Michel D, Marre E, Hampl W, Roczkos J, Muller S, Hertenstein B, et al. Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples. J Clin Microbiol 1995;33:3064-3067.
Boom R, Sol C, Weel J, Lettinga K, Gerrits Y, van Breda A, et al. Detection and quantitation of human cytomegalovirus DNA in faeces. J Virol Methods 2000;84:1-14.
Herfarth HH, Long MD, Rubinas TC, Sandridge M, Miller MB. Evaluation of a non-invasive method to detect cytomegalovirus (CMV)-DNA in stool samples of patients with inflammatory bowel disease (IBD): a pilot study. Dig Dis Sci 2010;55:1053-1058.
Ganzenmueller T, Kluba J, Becker JU, Bachmann O, Heim A. Detection of cytomegalovirus (CMV) by real-time PCR in fecal samples for the non-invasive diagnosis of CMV intestinal disease. J Clin Virol 2014;61:517-522.
Mokhtari M, Tavakkoli H, Rafiee A, Dibaj R. Assessment of relationship between active ulcerative colitis and cytomegalovirus infection among Iranian patients. Adv Biomed Res 2012;1:19.
Feasey NA, Healey P, Gordon MA. Review article: the aetiology, investigation and management of diarrhoea in the HIV-positive patient. Aliment Pharmacol Ther 2011;34:587-603.
Nahar S, Iraha A, Hokama A, Uehara A, Parrott G, Ohira T, et al. Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis. World J Gastroenterol 2015; 21:12667-12675.
Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wohrmann A, et al. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Infection 2005;33:345-349.
Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl 2005;11:881-890.
Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol 2002;13:277-287.
Sakr M, Hassanein T, Gavaler J, Abu-Elmagd K, Fung J, Gordon R, et al. Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. Transplantation 1992;53:786-791.
Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 2002; 8:362-369.
Arslan H, Inci EK, Azap OK, Karakayali H, Torgay A, Haberal M. Etiologic agents of diarrhea in solid organ recipients. Transpl Infect Dis 2007;9:270-275.
Wong NA, Bathgate AJ, Bellamy CO. Colorectal disease in liver allograft recipients -- a clinicopathological study with follow-up. Eur J Gastroenterol Hepatol 2002;14:231-236.
Kozuka T, Takenaka K, Shinagawa K, Masuda K, Ishihara T, Arimori Y, et al. Cytomegalovirus enteritis after autologous peripheral blood stem cell transplantation. Ann Hematol 2001;80:617-619.
Nomura K, Kamitsuji Y, Kono E, Matsumoto Y, Yoshida N, Konishi H, et al. Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin's lymphoma. Scand J Gastroenterol 2005;40:604-606.
Van den Brande J, Schrijvers D, Colpaert C, Vermorken JB. Cytomegalovirus colitis after administration of docetaxel-5-fluorouracil-cisplatin chemotherapy for locally advanced hypopharyngeal cancer. Ann Oncol 1999;10:1369-1372.
Kitahara M, Kanekiyo S, Yamamoto T, Watanabe Y, Takeda S, Ueno T, et al. [A case of cytomegalovirus colitis during chemotherapy for esophageal cancer].Gan To Kagaku Ryoho 2013; 40:2127-2129.
Oshima Y, Nishida K, Kawazoye S, Noda T, Arima F, Miyahara M, et al. Successful treatment of cytomegalovirus colitis with ganciclovir in a patient with adult T cell leukemia lymphoma: case report. J Chemother 1999; 11:215-219.
Quiros-Tejeira RE, Ament ME, Rivera-Penera T, Cortina G, Vargas JH. Cytomegalovirus enterocolitis in an immunocompetent infant host: another cause of treatable intractable diarrhea in infancy. J Pediatr Gastroenterol Nutr 1999;29:86-90.
Shimizu M, Ohta K, Wada H, Sumita R, Yachie A, Koizumi S. Cytomegalovirus-associated protracted diarrhoea in an immunocompetent boy. J Paediatr Child Health 2006;42:259-262.
Kishore J, Ghoshal U, Ghoshal UC, Krishnani N, Kumar S, Singh M, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 2004;53(Pt 11):1155-1160.
| Files | ||
| Issue | Vol 10 No 2 (2018) | |
| Section | Original Article(s) | |
| Keywords | ||
| Cytomegalovirus Stool Immunocompromised Diarrhea PCR | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
